Chinese biotech giant WuXi AppTec raises 2026 outlook after profit surge
WuXi AppTec raised its full-year guidance after net profit surged 62.4 per cent in the first nine months of 2026.
WuXi AppTec raised its full-year guidance after net profit surged 62.4 per cent in the first nine months of 2026.